Notice of Annual Meeting of Shareholders 2023

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand
Incorporated in New Zealand ARBN 609 017 969



Notice of Annual Meeting of Shareholders 2023


Notice is hereby given that the Annual Meeting of shareholders of AFT Pharmaceuticals Limited (AFT or
the Company) will be held at the Milford Cruising Club, 24 Craig Road, Milford, Auckland, New Zealand,
on Friday, 4 August 2023 commencing at 10.30am (New Zealand time).

Agenda

A Addresses

Our Chairman, David Flacks, and our Founder and Chief Executive Officer, Hartley Atkinson, will
provide an overview of the Company’s performance for the year ended 31 March 2023. There will
also be an opportunity for shareholders to ask questions.

B Resolutions

Shareholders will be asked to consider, and if thought fit, pass the following ordinary resolutions:

1. That the directors are authorised to fix the fees and expenses of Deloitte as
auditor for the 2024 financial year.

2. That Marree Atkinson be re-elected as a director of AFT Pharmaceuticals Limited.


Each resolution is an ordinary resolution and must be approved by a simple majority of the votes of
those shareholders entitled to vote and voting on the resolution.


See explanatory notes on each resolution below. No shareholder is restricted from voting on any
resolution.

The Board recommends unanimously that you vote in favour of all resolutions.

C General Business

To consider any other matter that may be brought properly before the Annual Meeting.


By Order of the AFT Pharmaceuticals Limited Board




David Flacks
Chairman

30 June 2023

Page | 2

Explanatory Notes


Resolution 1: Auditor’s Remuneration
Deloitte is automatically reappointed auditor of
the Company at the Annual Meeting pursuant
to the Companies Act 1993. The resolution
sought is to authorise the directors to fix the
remuneration of the auditor pursuant to section
207(S)(a) of the Companies Act 1993.
Resolution 2: Re-election of Maree Atkinson as a
Director
Marree was appointed as an executive director
by the shareholders of AFT on 4 September 2012
and was last re-elected in 2020. In accordance
with the applicable NZX listing rules and the
Company’s constitution, Marree retires by
rotation and, being eligible, offers herself for
re-election as a director of AFT at the meeting.
The Board unanimously supports Marree's re-
election and considers Marree to be a non-
independent director as she is an executive
officer and a discretionary beneficiary of the
majority shareholder of AFT.

Marree Atkinson
Executive Director
Marree has been involved in all aspects of AFT’s
business since its establishment in 1997,
including roles in sales, regulatory affairs,
customer services and logistics. Marree’s role as
Chief of Staff sees her involved in the
day-to-day running of AFT’s head office
including managing staffing requirements and
special projects involving AFT’s head and
affiliate offices. Marree is a registered nurse
previously practising at Waikato Hospital.

Page | 3

Important Information



Attendance at Meeting
All shareholders registered on the Company’s
share register at 5pm on Wednesday
2 August 2023 are entitled to attend and vote
at the meeting.
Voting and Proxies
Voting at the meeting shall be by way of a poll
of the Company's shareholders entitled to vote
and voting.
A shareholder entitled to attend and vote at
the meeting can appoint a proxy to attend and
vote on that shareholder’s behalf. A proxy
need not be a shareholder. The Chair of the
meeting may be appointed to act as proxy.
If the Chair of the meeting is appointed to act
as proxy and is not directed how to vote, the
Chair will vote in favour of all the resolutions.
If you do not name a person as your proxy but
otherwise complete the proxy form in full or your
named proxy does not attend the meeting, the
Chairman will act as your proxy and will only
vote in accordance with your express direction.
A shareholder wishing to appoint a proxy can
do so by visiting www.investorvote.co.nz
.
Shareholders will be required to enter their
CSN/Holder Number and postcode or country
of residence to complete the online
appointment.
Alternatively, shareholders can appoint a proxy
by completing the enclosed proxy form and
returning it to Computershare Investor Services
Limited by any of the methods specified on the
proxy form.
The proxy form must be received no later than
10.30am on Wednesday 2 August 2023 (being
48 hours prior to the meeting).




Webcast
The Annual Meeting will be webcast live. To view and
listen to the webcast, please visit
https://webcast.openbriefing.com/afp-agm-2023/
Note that shareholders joining by webcast will not be
able to vote at the meeting or ask questions. In order to
vote you will need to appoint a proxy in accordance
with the above instructions before 10.30am on
Wednesday 2 August 2023.
If you have any questions you would like
considered at the meeting, please send them to
investor.relations@aftpharm.com
in advance of
the meeting.
More Information
If you have any questions, or for more
information, please contact AFT’s Company
Secretary, at investor.relations@aftpharm.com